Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Once LABS commercializes in the U.S. market, stock price is

<< Previous

Bullboard Posts

Next >>

Comment by Starkickeron Jul 16, 2023 5:59pm

98 Views

Post# 35543382

RE:Once LABS commercializes in the U.S. market, stock price is

As long as they build the stock price on merit and don't pull the reverse split BS to get on the Nasdaq, which has a, what?, $4 minimum. A RS would be a huge setback for retail investor longs who bought in a year or more ago.

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features